医学
苯丙氨酸羟化酶
先天性代谢错误
儿科
四氢生物蝶呤
易怒
饮食管理
新生儿筛查
苯丙酮尿症
焦虑
苯丙氨酸
精神科
内科学
一氧化氮
氨基酸
化学
一氧化氮合酶
生物化学
作者
Alberto Burlina,Vincenzo Leuzzi,Marco Spada,Maria Teresa Carbone,Sabrina Paci,Albina Tummolo
标识
DOI:10.1080/03007995.2020.1847717
摘要
Phenylketonuria (PKU) is a rare autosomal recessive disorder caused by a deficiency of phenylalanine hydroxylase (PAH). Its prevalence is estimated to be 1:10,000 in Europe. PKU is the commonest congenital inborn error of metabolism. The aim of our study was to investigate the characteristics of clinical practice in relation to PKU in Italy, in order to raise awareness about the current management and therapeutic approaches adopted.Six Italian experts conducted a systematic literature review as well as an internal survey to investigate the relevant clinical aspects. Collectively, the expert panel managed a total of 678 PKU patients treated in the early stages of the condition over a 16-year period across six centers.The management of PKU varied markedly between centers, with differences in the composition of the multidisciplinary team, dietary treatments, compliance and adherence to management, tetrahydrobiopterin use, and patient follow-up. Patients were mostly managed by a pediatric reference center from the initial PKU diagnosis during newborn screening until adulthood, without transition to a specialized adult clinician. Fogginess, concentration reduction, low attention, anxiety, irritability, memory deficit, headache, and unstable mood were common features in patients with uncontrolled blood phenylalanine levels (generally above 600 µmol/L).A homogeneous and shared approach to the management of PKU patients is important. Our survey demonstrates the current management of PKU in Italy, with the aim of promoting the implementation of therapeutic strategies and follow-up, increased patient compliance and adherence, and the achievement of the phenylalanine level targets recommended by European Union guidelines. Emerging therapies are likely to become a standard treatment for patients unable to comply with diet therapy and maintain their phenylalanine levels below the threshold values.Supplemental data for this article is available online at https://doi.org/10.1080/03007995.2020.1847717.
科研通智能强力驱动
Strongly Powered by AbleSci AI